Differential diagnosis was blast crisis chronic myeloid leukemia (CML) and AML, with the final diagnosis of AML having BCR::ABL1 fusion, given more than 20% blasts expressing a myeloid immunophenotype in the bone marrow or peripheral blood [6]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.